Dna X (SONM) Research & Development (2018 - 2025)

Dna X (SONM) has 8 years of Research & Development data on file, last reported at $181000.0 in Q3 2025.

• Quarterly Research & Development fell 94.06% year-over-year to $181000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $16.5 million (up 242.82% YoY) and the FY2024 annual result came in at $13.0 million, up 631.49% from the prior year.
• Research & Development eased to $181000.0 in Q3 2025, from $3.4 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $11.2 million in Q4 2024 to a low of -$3.9 million in Q4 2023.
• A 5-year average of $3.1 million and a median of $2.7 million in 2022 frame the typical range for Research & Development.
• The widest YoY moves for Research & Development: up 1680.0% in 2023, down 359.54% in 2023.
• Tracing SONM's Research & Development over 5 years: stood at $10.2 million in 2021, then tumbled by 85.16% to $1.5 million in 2022, then slumped by 359.54% to -$3.9 million in 2023, then soared by 384.77% to $11.2 million in 2024, then plunged by 98.39% to $181000.0 in 2025.
• The last three Research & Development figures came in at $181000.0 (Q3 2025), $3.4 million (Q2 2025), and $1.6 million (Q1 2025), per Business Quant data.